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Susceptibility for infection-related glomerulopathy depends on non-
MHC genes. BALB/c mice infected with T,ypanosoma brucei and
treated seven days after inoculation with Diminazene aceturate develop
polyclonal B-cell stimulation, including production of antibodies to
known nephritogenic autoantigens and glomerular disease associated
with severe albuminuria. To investigate if the susceptibility for glomer-
ular disease in this model is linked to MHC or non-MHC genes, we
studied this disease in six mouse strains that were partly congenic for
their MHC and partly congenic for their non-MHC genes. The course of
the infection was measured by parasitemia and related to (auto)anti-
body production, proteinuria and glomerular deposition of immuno-
globulins. The mouse strains could be divided into two groups. The first
group consisted of the C57BL/6 (H-2'), C57BL/l0 (H2b) and Bl0.D2
(H-2") strains, which proved to be relatively resistant to infection with
Trypanosoma brucei (that is, spontaneous survival >25 days). In sera
of these mice antibodies to a broad range of antigens could be found 14
days after inoculation; no proteinuria was observed. The second group
consisted of the BALB/c (H-2"), BALB.B (H-2") and DBA/2 (H-2")
strains, which were relatively susceptible to the infection. In these
animals proteinuria occurred and a broad polyclonal B-cell stimulation
was seen 42 days after inoculation. No correlation was found between
the specificity of circulating antibodies and the occurrence of protein-
uria or a glomerular fluorescence pattern. These results indicate that in
this model non-MHC genes govern the outcome of the infection as well
as the development of polyclonal B-cell stimulation and proteinuria.
Concerning the glomerulopathy, a discrepancy is observed between
glomerular immunoglobulin staining patterns and the development of
proteinuria. Therefore, an additional pathogenetic role for non-immu-
noglobulin humoral factors must be considered.
In general, autoimmune diseases seem to occur more often in
genetically predisposed persons [1]. Epidemiologic as well as
experimental studies have demonstrated the inheritance pat-
terns to be multigenic. Several reports have demonstrated that
certain MHC genes are related to a higher susceptibility for
autoimmune diseases. For example HLA-DR2 and HLA-DR3
are seen more often in lupus prone patients [21, of whom the
HLA-DR2 patients develop glomerular disease more often [3,
41. However, neither gene is necessary or sufficient, since many
people carry the haplotype without being affected and many
patients do not carry the haplotype at all. Therefore, it is
important to relate the genetic composition to possible patho-
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genetic factors as this may lead to a better understanding of
pathogenesis as well as disease inheritance. The glomerular
disease described in BALB/c mice induced by Trypanosoma
brucei infection is a suitable model to study such relationships,
as glomerular disease occurs together with autoantibody pro-
duction while antibodies reactive with Trypanosomal antigens
do not seem to be involved in the development of the renal
disease [5].
To investigate in this model whether the susceptibility for
developing renal disease and the production of autoantibodies is
linked to MHC or non-MHC genes, we studied the development
of renal disease during Trypanosoma brucei infection in six
mouse strains either congenic for their MHC or congenic for
their background with the previously-described BALB/c mice.
Methods
Animals
BALB/c mice were bred in our own facilities. Female
BALB.B, C57BL/l0 (BlO), C57BL16 (B6), B10.D2 and DBAI2
mice were purchased from Harlan OLAC (Zeist, the Nether-
lands). The genetic composition is shown in Table 1.
Parasites
A stabilate of Trypanosoma brucei (STIB 348c variant A) was
obtained from the Department of Pathology of the Bernard-
Nocht-Institut für Schiffs- und Tropenkrankheiten (Hamburg,
Germany). This stabilate was expanded after a passage in an
irradiated (500 rad) BALB/c mouse. Blood from this animal
containing 108 parasites/ml was diluted in glycerol and saline
and cryopreserved in batches of 40 d samples.
Inoculation
Cryopreserved blood was diluted in saline, up to 1000 para-
sites per ml. Each animal was inoculated with 0.1 ml (± 100
parasites) i.p.
Drug administration
Diminazene aceturate (Berenil®; Hoechst AG, Frankfurt am
Main, Germany) was diluted up to 5 mg/mI in saline and
administered i.p. in a dosage of 40 mg/kg, to achieve a more
protracted course of the disease as has been previously shown
[51.
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Table 1. Mouse strains used
Strain Non-MHC MHC
BALB/c BALB dl0 BlO b
B6 B6 b
DBA/2 DBA d
BALB.B BALB b
BlO.D2 BlO d
Experimental design
Two sets of experiments were performed consecutively ac-
cording to the protocols described [5]. In the first set of
experiments, seven mice from each of the examined strains
were inoculated with Trypanosoma brucei, while five animals
from each strain served as controls. In the second set of
experiments seven mice of each strain were inoculated with
Trypanosoma brucei and treated seven days after infection with
Diminazene aceturate (Tr + Da +). As a control Diminazene
aceturate was administered to five animals of each strain (Tr —
Da +). Albuminuria was measured weekly. Serum was ob-
tained every two weeks. Parasitemia was measured every other
day in the first set of experiments, while it was detected weekly
in the second experiment set.
All animals were sacrificed 42 days after inoculation because,
based on earlier observations [5], full blown disease was
expected to have developed by then.
Parasitemia
Parasites were counted in a smear of tail blood, stained with
Leishman's stain. The results were expressed as number of
parasites per 100 erythrocytes.
Albuminuria
Mice were held in metabolic cages for 18 hours with free
access to water and food. The albumin concentration in urine
was measured by rocket electrophoresis.
Histological methods
All kidneys were perfused in vivo with PBS for two minutes,
prior to sacrifice of the animals. For light microscopy, the
tissues were fixed in 10% buffered formalin, dehydrated, and
embedded in Paraplast® (Amsteistad, Amsterdam, The Nether-
lands). Sections were cut 5 sm thick and stained with hema-
toxylin-eosin (H&E) and periodic acid-Schiff reagent (PAS),
according to standard methods. For direct immunofluorescence
studies kidney specimens were snap frozen and stained as
described elsewhere [61. In short, 2 jsm sections were cut in a
cryostat, air dried, and fixed in acetone/ethanol (50/50) for five
minutes and then postfixed in 100% ethanol for 10 minutes
before being incubated for one hour with monospecific rabbit-
anti-mouse-FITC-conjugated immunoglobulins (Nordic Immu-
nology, Tilburg, The Netherlands) directed against mouse 1gM,
IgG, IgG3 and C3. Cross reactivity of the IgG3 antibodies with
other IgG subclasses was checked by staining kidney specimens
of mice with GVH (chronic graft vs. host disease) induced
nephritis. In murine GVH-induced nephritis all IgG subclasses
except IgG3 are known to be involved [7]. Fluorescence pat-
terns were scored in a semiquantitative manner attributing a
"—" for absence of staining, "+" for staining, and "++" for
strong staining.
Preparation of antigens and antisera
Renal tubular epithelial antigens (RTE), glomerular basement
membrane antigens (GBM), DPPIV, and gp330 were prepared
and characterized as described elsewhere [8, 9]. Type IV
collagen, antibodies directed against type IV collagen, and
laminin were a gift of Prof. J.-M. Foidart (Dept. of Biology,
University of Liege, Belgium). Preparation and characteriza-
tion of these antigens and antibodies have been described [10,
11]. EHS mouse laminin was obtained from Sigma (Sigma
Chemical Co. Ltd., Dorset, UK). Dinitrophenol coupled to rat
serum albumin (DNP-RSA) was provided by Prof. M.R. Daha
(Department of Nephrology, University Hospital of Leiden).
ELISA studies
Antibodies to various known nephritogenic antigens and to
DNP-RSA were measured in sera of control and diseased mice
to evaluate the degree of polyclonal B-cell stimulation and to
correlate autoantibody production to the development of renal
disease. For the detection of antibodies to RTE, GBM, DPPIV,
gp330, laminin, collagen type IV, and DNP ELISA studies were
performed as described [8, 12, 13]. In experiment 1, antibodies
were detected in day 14 sera as this was the latest time point
sera could be obtained from most mice. In experiment 2, sera
obtained 28 and 42 days after inoculation were used. At each
time point and of each strain antibodies were measured in four
experimental and four control sera in most instances. All sera
were tested in two dilutions (1/40 and 1/80, both in duplo). As
the extinction for the 1/80 dilution was always much lower than
for the 1/40 dilution, the results of the 1/40 diluted sera were
used. Peroxidase-conjugated goat anti-mouse Ig (DAKO-
PATTS) was applied as second step. As a positive control for
the coating procedure of the antigens, we used specific rabbit
and goat antisera. The positive control for RTE was serum of
mice with chronic graft-versus-host disease known to react with
these antigens [14]. As a negative control, each serum was
tested in the same dilutions on a BSA-coated well. In all studies
a standard dilution curve from a reference serum pool of
BALB/c mice 42 days after inoculation with parasites was
included. The reaction products were quantified by measuring
extinction at 492 nm with a Titertek Multiscan (Amstelstad by,
Zwanenburg, The Netherlands).
Statistical analysis
To analyze the significance of the differences obtained in the
various experiments between experimental and control mice an
unpaired Student's t-test was used. The differences with a P
value <0.05 were considered to be significant. Individual mice
were considered to be albuminuric when their albuminuria in 18
hours exceeded the mean plus twice the standard deviation of
control mice.
Results
Parasitemia and survival
Experiment 1. After inoculation with Trypanosoma brucei all
mice, regardless of the strain used, developed a first parasitemic
peak between day 6 and 7. Hereafter the mouse strains could be
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Fig. 1. Mean value of the percentage of parasites for each strain (N = 7). A. Experiment 1 (Tr + Da —). B. Experiment 2 (Tr + Da +). Symbols
are:(——)BALB/c;(.-i--)B6;(-.-)B1O;(-€-)DBA/2;(x)BALB.B;(+)Bl0.D2.
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Fig. 2. Experiment 1 (Tr + Da —). A. Percentage of mice from each strain with an albuminuria exceeding the mean plus twice the standard
deviation of control mice. Symbols are as in B except: (—+--) BlO; (—+(--) B6. B. Mean of albuminuria in 18 hours (± SEM). Symbols are: (—)
BALB/c; ( —i--) B6; (-..) BlO; (-0-) DBA/2; ( >' ) BALB.B; ( >) BlO.D2.
divided into two groups (Fig. la). In the first group (BALB/c,
BALB.B, and DBAI2) the parasitemia rose rapidly and peaked
after day 12. The animals of this group died between day 14
(DBA!2) and day 21 (BALB/c and BALB.B) after inoculation.
In the second group of strains (B 10, B6, and Bl0.D2) para-
sitemia rose more slowly after day 12, although in individual
mice one or two consecutive parasitemic peaks were seen.
These mice died later than those in the first group, between 25
(B6) and 30 (BlO, B10.D2) days after inoculation.
Experiment 2. In the second set of experiments all strains
showed a similar parasitemia curve (Fig. ib). Although the
height of the parasitemia was different in the individual strains,
these curves shared several characteristics. They all showed a
parasitemic peak on day 7 as in experiment 1, but now followed
by a slow rise in parasitemia in all strains after day 21. Most
animals survived until day 42, the end of the observation
period, except for three B6, two B 10 and four B lO.D2 mice that
died between 28 and 37 days post-inoculation, respectively.
Albuminuria
Experiment 1. During the first experiment no albuminuria, as
defined above, was measured in B6 and B10.D2 mice except for
one mouse of each strain (78 and 134 g/18 hours, respectively).
The other four strains showed albuminuria (Fig. 2 a and b).
Experiment 2. Considering the albuminuria of the second
experiment the strains could be divided in the same two groups
(Fig. 3 a and b) as defined with the parasitemia in experiment 1.
BALB/c, BALB.B, and DBAI2 strains developed proteinuria
according to the criteria mentioned above. However, of the
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Strain Immunofluor.
ALB
D14
Lam
D14
Col
Dl4
GBM
D14
RTE
D14
DPP
D14
GP330
D14
DNP
D14
BALB/c 1gM ms+ + ii + + + — + + + + +
IgG ms++ Ii +
BlO IgMms++li+ + + + + + + + +
IgG ms++ ii +
B6 IgMms++li+ — + + + + + + +
IgG ms+
DBA/2 1gM ms++ + — — + — — + +
IgG ms++
BALB.B 1gM ms++ ii ++ + + — — — — + +
IgG ms++ ii +
BlO.D2 1gM ms++ Ii + — + + + + + + -I-
IgG ms++
Presence "+" or absence "—" of significant difference in extinction between sera of experimental and control mice in unpaired t-test, for
antibodies to laminin (LAM), collagen type IV (Col), glomerular basement membrane (GBM), renal epithelial antigens (RTE), DPPIV (DPP),
gp330, and DNP. Abbreviations are Immunofluor., immunofluorescence pattern for 1gM and IgG; ms, mesangial, capillary loop; gr, granular; Ii,
linear; "+" presence of staining, "++" strong staining; albuminuria (ALB) according to Fig. 2.
BALB/c and DBAJ2 strains all experimental mice were albu-
minuric, while of the BALB .B strain only five out of seven mice
became albuminuric (Fig. 3a). Moreover, the height of the
albuminuria varied (Fig. 3b). The BlO, B6 and B10.D2 strains
did not become albuminuric, although two BlO mice had
albuminuria values up to 78 ig/l8 hours. Mean value of control
BlO mice was 23 g/18 hours (standard 15 tg/l8 hr). The means
of the control values of all strains in both experiments ranged
between 20 and 50 g/18 hr.
Immunofluorescence
Experiment 1. Immunofluorescence studies of the kidneys of
all infected mice of experiment 1 (Table 2), showed staining for
1gM in the mesangium and along the capillary loop in a linear
pattern. IgG was detected in the mesangium in these mice and
along the capillary wall in a faint linear pattern in BALB/c,
BALB.B and BlO experimental mice. lgG3 was present in the
same distribution pattern and intensity as IgG, except for
B l0.D2 and B 10 mice where IgG3 staining was little less bright
than IgG.
Experiment 2. Immunofluorescence of the kidneys of mice
from the second experiment (Table 3) all showed mesangial
staining for 1gM and IgG. Along the capillary loop 1gM was seen
again in a linear pattern in all mice, whereas IgG was seen in a
granular pattern in BALB/c mice and in a linear pattern in B6,
BALB.B, and B10.D2 mice. IgG3 showed a staining pattern
similar to IgG in BALBIc, BlO, B6, and BALB.B mice. While
IgG3 staining was less intense than IgG staining in DBAI2 and
B10.D2 mice.
In both experiments the fluorescence patterns were similar
for all mice within each group.
Polyclonal B-cell stimulation
All mouse strains showed antibody production to DNP-RSA
on all moments measured, except for the B6 strain on day 42. A
wide production of antibodies to gp330 was detected as well
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Fig. 3. Experiment 2 (Tr + Da +). A. Percentage of mice from each strain with an albuminuria exceeding the mean plus twice the standard
deviation of control mice. B. Mean of albuminuria in 18 hours (± sI4). Symbols are: (—•—) BALB/c; (-+—) B6; (-+-) BlO; (-€3—) DBAI2; (X)
BALB.B; ( G-) Bl0.D2.
Table 2. Experiment 1, day 14
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Table 3. Experiment 2, day 42
Strain Immunofluor.
ALB
D42
Lam
D42
Cot
D42
GBM
D42
RTE
D42
DPP
D42
GP330
D42
DNP
D42
BALB/c 1gM ms++ li+ + + + + + + + +
IgG ms++ gr+
BlO IgMms++li+ — + — + - +
lgG ms++
B6 IgMms++li+ — — — +
IgG ms++ li+
DBA/2 1gM ms++ li+ + — — + — + + +
IgG ms++
BALB.B 1gM ms++ li+ + + + + + + + +
IgG ms++ Ii+
BlO.D2 lgMms++li+ — — — — — + + +
IgG ms+ li+
Presence "+" or absence "—" of significant difference in extinction between sera of experimental and control mice in unpaired f-test, for
antibodies to laminin (LAM), collagen type IV (Col), glomerular basement membrane (GBM), renal epithelial antigens (RTE), DPPIV (DPP),
gp330, and DNP. Abbreviations are: Immunofluor., immunofluorescence pattern for 1gM and IgG; ms, mesangial, capillary loop; gr, granular; Ii,
linear; "+" presence of staining, "++" strong staining; albuminuria (ALB) according to Fig. 3.
Table 4. Experiment 2, day 28
Strain
ALB
D28
Lam
D28
Col
D28
GBM
D28
RTE
D28
DPP
D28
GP330
D28
DNP
D28
BALB/c — + + — + + + +
BlO — + — — — + i- +
B6 — — — + — + — +
DBA/2 + — + — — — + +
BALB.B — — + — + — + +
BlO.D2 — + — + — — + —
Presence "+" or absence —" ofsignificant difference in extinction
between sera of experimental and control mice in unpaired f-test, for
antibodies to laminin (LAM), collagen type IV (Col), glomerular
basement membrane (GBM), renal epithelial antigens (RTE), DPPIV
(DPP), gp330, and DNP, 28 days after inoculation. Albuminuria (ALB)
is according to Fig. 2.
(Tables 2 and 3). Considering the antibody production patterns
the mouse strains could be divided in the same two groups as
described in association with proteinuria and parasitemia
(BALB/c, BALB.B vs. B6, BlO, Bl0.D2). The first showed
antibodies to all antigens measured on day 42 of the second
experiment (Table 3) while the others showed, in contrast,
antibodies to all antigens measured on day 14 of the first
experiment (Table 2). Sera of experiment 2 day 28 showed an
intermediate pattern (Table 4). DBA/2 mice were an exception,
showing an intermediate antibody production pattern on all
moments measured.
Discussion
In this paper the role of MHC and non-MHC in the induction
of glomerular disease during experimental Trypanosoma brucei
infection was investigated. The six mouse strains studied could
be divided into two groups according to their reaction patterns
following infection with Trypanosoma brucei (B 10, B6, B 10.D2
vs. BALB/c, BALB.B and DBA/2), concerning parasitemia,
proteinuria, and antibody production. This indicates a role for
the background genes in immunoregulation, since the groups
corresponded with the non-MHC (BALB/c, BALB.B vs. BlO
and B lO.D2) and not with the MHC genes (Table 1). However,
if the mice had a BALB background, some influence of MHC
genes was seen, because the height and the incidence (7 of 7 vs.
5 of 7) of albuminuria in BALB/c and BALB.B mice were not
identical during the second experiment (Fig. 3 a and b).
The mouse strains with early antibody production to a limited
amount of antigens (day 14 of experiment 1) produced antibod-
ies to a greater variety of antigens later in the disease (day 42 of
experiment 2). This phase was associated with proteinuria (Fig.
3, Table 3). However, the polyclonal stimulation itself was no
clue to the occurrence of the proteinuria, because, except for
BlO mice, none of the mouse strains in which antibodies could
be detected to all antigens tested on day 14 of experiment 1,
developed proteinuria in the first nor in the second experimental
protocol (Tables 2 and 3).
No direct relationship was seen between the antibodies to a
specific antigen and the occurrence of proteinuria (Tables 2, 3
and 4) nor was there a specific glomerular fluorescence pattern.
Although in the first set of experiments the presence of IgG
along the capillary loop seemed to be related to proteinuria, this
was not the case in the second set of experiments. Detectable
antibodies to laminin, collagen type IV or GBM did not coincide
with a linear fluorescence pattern as might have been expected
from previous studies [15]. Nor could antibodies to RTE,
DPPIV, and gp330 account for a granular fluorescence pattern,
as was expected from the literature [9, 16, 17]. However, in a
recent study Cavalot et al [18] showed that antibodies to laminin
and collagen type IV, due to polyclonal B-cell activation, could
be present in the circulation without binding to the glomerular
capillary wall, even after isolated kidney perfusion with serum
containing these antibodies. The lack of binding of these
antibodies was not explained. Therefore we can only speculate
that in this model, the lack of binding is due to either the low
titer of antibodies present or to a lack of exposure of the
corresponding epitopes.
We looked in more detail for IgG3 since this isotype was
reported to be nephritogenic [19, 20]; we observed a prominent
binding of IgG3 in the glomeruli of Trypanosoma brucei in-
fected BALB/c mice [5]. No clear differences of IgG3 staining
patterns were seen between strains. In all strains the IgG3
staining pattern was similar to that of IgG.
If the proteinuria in both experiments and in all strains could
be explained by a similar pathogenetic mechanism, neither an
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immune-complex mediated, nor a polyclonal B-cell stimulation-
related pathogenesis could be supported in this model, although
antibodies to a nephritogenic antigen not tested might still be
responsible.
The absence of albuminuria in the B6, BlO and Bl0.D2
strains during the second experiment could not be explained by
the fact that these mice were more severely diseased, as neither
their clinical behavior nor their parasitemia were significantly
different from those of the other strains. Moreover, the clinical
status of the mice in the first experiment was even worse, while
this did not prevent these mice from developing proteinuria.
However, the cause of death of these mice remains uncertain. It
is more likely that a different factor than immunoglobulins is
responsible for the proteinuna in this model. This is a new point
of view in research for the pathogenetic mechanisms of immu-
nologically mediated glomerulonephritis, although the role of
several humoral factors in autoimmune diseases is under cur-
rent study [3, 21—251.
These conclusions are analogous with those that were drawn
from the experiments looking for the factors responsible for the
inherited resistance or susceptibility to Trypanosoma brucei
infection [26, 271. In these studies susceptibility of mice for
Trypanosoma brucei infection was shown to involve at least
two genes and was not especially linked to the MHC. Even
more surprising was the finding that susceptibility (survival)
was not linked to specific anti-Trypanosomal antibody produc-
tion [26, 27]. Humoral factors such as prostaglandins [28],
polyamide oxidase (PAO) and zinc [29] have been shown to
play a role in the immune modulation during experimental
Trypanosoma brucei infection. Others have postulated that the
suppressive factors occurring during Trypanosoma brucei in-
fection are involved in the higher susceptibility of some mouse
strains [30]. This immunosuppression is mediated by macro-
phages [31] which are induced, through soluble factors secreted
by the Trypanosomes, to express less IL-2R and secrete less
IL-2.
We conclude that in this model non-MHC genes determine
the outcome of the infection as well as the development of
polyclonal B-cell stimulation and proteinuria. The glomerulo-
pathy, however, shows a discrepancy between glomerular
immunoglobulin staining patterns and the development of pro-
teinuria. Nor can any of the known nephritogenic antibodies be
held responsible for the proteinuria. Further studies are war-
ranted to identify the role of humoral factors, cellular products
different from immunoglobulins, in the induction of proteinuria
in infection related glomerulopathy, with special attention to-
wards the different compartments of the cellular immune sys-
tem,
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